WASHINGTON, April 26, 2019 – Alliance for Aging Research President and CEO Susan Peschin, MHS, issued the following statement on the proposed alternative inpatient new technology add-on payment pathway for transformative devices in the Center for Medicare and Medicaid’s (CMS) FY 2020 Inpatient Prospective Payment Systems:
The Alliance for Aging Research applauds CMS’s proposal to create an alternative payment pathway to increase access for breakthrough medical devices. The Alliance supported establishing the Breakthrough Devices Program at the U.S. Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) as part of the 21st Century Cures Act. The program created a priority review process for medical devices intended for use in patient populations with life-threatening illnesses and for areas of unmet need. But, while the new FDA program expedited device review and market entry, it did not necessarily increase patient access. The proposed CMS add-on payment pathway is a major step toward getting transformational treatments into the lives of more Medicare beneficiaries that need them.
We believe timely access to cutting-edge medical devices is vital to the health and independence of older adults. Improvement in function and well-being is what healthcare should be about—and that is priceless.
About the Alliance for Aging Research:
The Alliance for Aging Research is the leading nonprofit organization dedicated to accelerating the pace of scientific discoveries and their application to vastly improve the universal human experience of aging and health. The Alliance was founded in 1986 in Washington, D.C., and has since become a valued advocacy organization and a respected influential voice with policymakers. For more information, please visit www.agingresearch.org.
Vice President of Communications